# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutic...
During Wednesday's morning trading, 47 companies set new 52-week lows.
Monday morning saw 115 companies set new 52-week lows.
European Biotech Acquisition Corp. (the "Company") today announced it received a notice on May 28, 2021 from the Nasdaq...